Finance

Lists
Why is BCT up 9.54%?
Dive Deeper
BCT:TSE
Briacell Therapeutics Corp
CA$5.05
+9.54%
(+0.44) 1D
Nov 6, 11:30:01 AM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BCT...
Open
CA$4.60
High
CA$5.05
Low
CA$4.60
Mkt. cap
44.22M
Avg. vol.
5.42K
Volume
5.83K
52-wk high
CA$18.00
52-wk low
CA$3.68
EPS
-CA$9.76
Beta
1.03
Shares outstanding
8.73M
No. of employees
31
Open
CA$4.60
High
CA$5.05
Low
CA$4.60
Mkt. cap
44.22M
Avg. vol.
5.42K
Volume
5.83K
52-wk high
CA$18.00
52-wk low
CA$3.68
EPS
-CA$9.76
Beta
1.03
Shares outstanding
8.73M
No. of employees
31
News stories
From web sources and news partners
About Briacell Therapeutics Corp
CEO-
Employees31
Founded2006
HeadquartersWest Vancouver, British Columbia, Canada
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.56M
5.92M
5.84M
10.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76M
1.61M
1.78M
2.18M
Operating expense
8.32M
7.53M
7.62M
12.58M
Total operating expenses
8.32M
7.53M
7.62M
12.58M
Operating income
-8.32M
-7.53M
-7.62M
-12.58M
Other non operating income
-69.20K
211.78K
261.07K
-104.91K
EBT including unusual items
-8.28M
-7.30M
-7.24M
-12.51M
EBT excluding unusual items
-8.37M
-7.30M
-7.24M
-12.62M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.20M
-7.22M
-7.16M
-12.32M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
48.48K
105.64K
219.22K
170.94K
Interest expense
-
-
-29.63K
-
Net interest expenses
48.48K
105.64K
189.59K
170.94K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.30M
-7.50M
-7.59M
-12.55M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps